Literature DB >> 16413547

LATS2-Ajuba complex regulates gamma-tubulin recruitment to centrosomes and spindle organization during mitosis.

Yoshinori Abe1, Miho Ohsugi, Keiko Haraguchi, Jiro Fujimoto, Tadashi Yamamoto.   

Abstract

LATS2 is a human homolog of Drosophila tumor suppressor lats/warts, and encodes a mitotic kinase whose physiological roles remain to be elucidated. We performed yeast two-hybrid screening and identified a LIM protein Ajuba, as a binding partner of LATS2. LATS2 was localized to the centrosomes throughout the cell cycle and was associated with Ajuba during mitosis, contributing to latter's mitotic phosphorylation. Depletion of LATS2 or Ajuba impaired centrosomal accumulation of gamma-tubulin and spindle formation at the onset of mitosis, suggesting that the LATS2-Ajuba complex regulates organization of the spindle apparatus through recruitment of gamma-tubulin to the centrosome.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16413547     DOI: 10.1016/j.febslet.2005.12.096

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  43 in total

1.  Ajuba Preferentially Binds LXRα/RXRγ Heterodimer to Enhance LXR Target Gene Expression in Liver Cells.

Authors:  Hongyan Fan; Weibing Dong; Qi Li; Xiuqun Zou; Yihong Zhang; Jiamin Wang; Shengxian Li; Wei Liu; Ying Dong; Haipeng Sun; Zhaoyuan Hou
Journal:  Mol Endocrinol       Date:  2015-09-21

2.  Stability of the LATS2 tumor suppressor gene is regulated by tristetraprolin.

Authors:  Hyun Hee Lee; Mai-Tram Vo; Hyo Jeong Kim; Unn Hwa Lee; Chae Won Kim; Hong Kyeung Kim; Myoung Seok Ko; Won Hyuck Lee; Seung Joo Cha; Young Joo Min; Dae Hwa Choi; Ho Seok Suh; Byung Ju Lee; Jeong Woo Park; Wha Ja Cho
Journal:  J Biol Chem       Date:  2010-03-24       Impact factor: 5.157

Review 3.  Hippo Pathway: An Emerging Regulator of Craniofacial and Dental Development.

Authors:  J Wang; J F Martin
Journal:  J Dent Res       Date:  2017-07-12       Impact factor: 6.116

4.  A positive feedback loop between the p53 and Lats2 tumor suppressors prevents tetraploidization.

Authors:  Yael Aylon; Dan Michael; Ayelet Shmueli; Norikazu Yabuta; Hiroshi Nojima; Moshe Oren
Journal:  Genes Dev       Date:  2006-10-01       Impact factor: 11.361

5.  LIM-domain protein AJUBA suppresses malignant mesothelioma cell proliferation via Hippo signaling cascade.

Authors:  I Tanaka; H Osada; M Fujii; A Fukatsu; T Hida; Y Horio; Y Kondo; A Sato; Y Hasegawa; T Tsujimura; Y Sekido
Journal:  Oncogene       Date:  2013-12-16       Impact factor: 9.867

6.  TRIP6 inhibits Hippo signaling in response to tension at adherens junctions.

Authors:  Shubham Dutta; Sebastian Mana-Capelli; Murugan Paramasivam; Ishani Dasgupta; Heather Cirka; Kris Billiar; Dannel McCollum
Journal:  EMBO Rep       Date:  2017-12-08       Impact factor: 8.807

7.  Hippo/Yap signaling controls epithelial progenitor cell proliferation and differentiation in the embryonic and adult lung.

Authors:  Alexander W Lange; Anusha Sridharan; Yan Xu; Barry R Stripp; Anne-Karina Perl; Jeffrey A Whitsett
Journal:  J Mol Cell Biol       Date:  2014-12-05       Impact factor: 6.216

8.  Ste20-related protein kinase LOSK (SLK) controls microtubule radial array in interphase.

Authors:  Anton V Burakov; Olga N Zhapparova; Olga V Kovalenko; Liudmila A Zinovkina; Ekaterina S Potekhina; Nina A Shanina; Dieter G Weiss; Sergei A Kuznetsov; Elena S Nadezhdina
Journal:  Mol Biol Cell       Date:  2008-02-20       Impact factor: 4.138

9.  Arpc1b, a centrosomal protein, is both an activator and substrate of Aurora A.

Authors:  Poonam R Molli; Da-Qiang Li; Rozita Bagheri-Yarmand; Suresh B Pakala; Hiroshi Katayama; Subrata Sen; Jyoti Iyer; Jonathan Chernoff; Ming-Ying Tsai; Sujit S Nair; Rakesh Kumar
Journal:  J Cell Biol       Date:  2010-07-05       Impact factor: 10.539

Review 10.  Making the Auroras glow: regulation of Aurora A and B kinase function by interacting proteins.

Authors:  Mar Carmena; Sandrine Ruchaud; William C Earnshaw
Journal:  Curr Opin Cell Biol       Date:  2009-12       Impact factor: 8.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.